ClinicalTrials.govpublic full text
ARX788 for Treating Patients With HER2-low Locally Advanced Unresectable or Metastatic Breast Cancer
her2 low breast carcinoma, triple negative breast cancer, hormone-receptor-positive breast cancer, hormone receptor positive breast carcinoma, antibody-drug conjugate, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 916096
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.